...
首页> 外文期刊>Stem cell research >CD133-enriched Xeno-Free human embryonic-derived neural stem cells expand rapidly in culture and do not form teratomas in immunodeficient mice - ScienceDirect
【24h】

CD133-enriched Xeno-Free human embryonic-derived neural stem cells expand rapidly in culture and do not form teratomas in immunodeficient mice - ScienceDirect

机译:富含CD133的不含Xeno的人类胚胎来源的神经干细胞在培养中迅速扩增,并且在免疫缺陷小鼠中不形成畸胎瘤-ScienceDirect

获取原文
           

摘要

Common methods for the generation of human embryonic-derived neural stem cells (hNSCs) result in cells with potentially compromised safety profiles due to maintenance of cells in conditions containing non-human proteins (e.g. in bovine serum or on mouse fibroblast feeders). Additionally, sufficient expansion of resulting hNSCs for scaling out or up in a clinically relevant time frame has proven to be difficult. Here, we report a strategy that produces hNSCs in completely “Xeno-Free” culture conditions. Furthermore, we have enriched the hNSCs for the cell surface marker CD133 via magnetic sorting, which has led to an increase in the expansion rate and neuronal fate specification of the hNSCs in vitro. Critically, we have also confirmed neural lineage specificity upon sorted hNSC transplantation into the immunodeficient NOD-scid mouse brain. The future use or adaptation of these protocols has the potential to better facilitate the advancement of pre-clinical strategies from the bench to the bedside.
机译:产生人类胚胎来源的神经干细胞(hNSC)的常用方法会导致细胞安全性受损,这是由于将细胞维持在含有非人类蛋白质的条件下(例如在牛血清中或在小鼠成纤维细胞饲养细胞中)。另外,已证明很难在临床相关的时间范围内充分扩展所得的hNSC,以进行横向扩展或扩展。在这里,我们报告了一种在完全“无异种”培养条件下生产hNSC的策略。此外,我们已经通过磁性分选丰富了hNSCs的细胞表面标记CD133,这导致了hNSCs的体外扩增速率和神经元命运规格的增加。至关重要的是,我们还证实了将hNSC分选移植到免疫缺陷的NOD-scid小鼠大脑中的神经谱系特异性。这些协议的未来使用或改编有可能更好地促进临床前策略从实验台到床边的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号